Q&A: How 3PLs are navigating the latest pharma trends
Pharmaceutical third-party logistics (3PL) providers are moving beyond traditional warehousing into more holistic and strategic commercialization support. At the same…
Partner Content
-
-
Accelerate post-approval research by streamlining the entire study lifecycle
As oncology therapies mature, post-approval research is essential to supporting regulatory commitments, label expansion, and real-world adoption—often under tight timelines.…
-
Quality by design: The impact of disconnected systems on clinical data
As clinical trials become more digitalised, the data landscape is expanding faster than the processes designed to control it. Electronic…
-
Podcast: The growth of clinical trials and research in Israel
Israel has a robust and growing clinical trials ecosystem. This podcast explores the factors that what make Israel such an…
-
The Ovarian Cancer Opportunity: Overcoming Complexity in Global Studies
Each year in the US, more than 21,000 women will receive a new diagnosis of ovarian cancer according to the…
-
Trends in Renal Research: Nephrology’s Shift to Focus and Precision
Nephrology has long been a difficult space for drug development: trials were slow, complex, high cost, and often unrewarding, constrained…
-
Streamline data capture and automate EHR-to-EDC data transfer
As clinical trial protocols grow more complex, so does the burden on research sites managing data collection and entry. Manual…
-
Vitamin E TPGS ─ Emerging Applications in Novel Parenteral Drug Delivery Systems
Abstract d-α-Tocopheryl polyethene glycol 1000 succinate (TPGS) has long served as a safe, multifunctional excipient in oral drug delivery, where…
-
An essential framework to navigating technical challenges in contemporary OSD development
As requirements shift toward more complex, value-added solid formats and increased outsourced manufacturing, oral solid delivery (OSD) demand is expected…
-
Overcoming material constraints: aseptic filling solutions for rare or expensive APIs
Sterile fill-finish is the critical final step of injectable drug production, ensuring patient safety by preventing microbial, bacterial, and particulate…